Venetoclax Plus Gilteritinib for FLT3-Mutated Relapsed/Refractory Acute Myeloid Leukemia | Journal of Clinical Oncology

  • 📰 medical_xpress
  • ⏱ Reading Time:
  • 20 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 11%
  • Publisher: 51%

United Kingdom Headlines News

United Kingdom Latest News,United Kingdom Headlines

Improving drug therapy for relapsed leukemia northwesternu nejm

); response occurred rapidly after achieving at least BM remission , if needed, for count recovery after achieving BM remission; and using azole antifungals to reduce fungal infections with appropriate venetoclax dose reductions.

Although survival reported here is similar to that reported in ADMIRAL, VenGilt response rates and OS are encouraging, as our study included all salvage patients , whereas ADMIRAL included only first relapse/primary refractorypatients. Furthermore, this study included a substantially higher proportion of patients who received ≥ 1 prior FLT3 TKI compared with ADMIRAL (59%

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 101. in UK

United Kingdom Latest News, United Kingdom Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Nuclear flamingos and deep-fried elephants invade Fallout 4's Nuka WorldThe Mutant Menagerie—Nuclear Safari mod adds new exotic and mutated creatures to Fallout 4's final expansion. I'm loving it for the most part. Some of the animals look bad but it's definitely Emersive
Source: pcgamer - 🏆 38. / 67 Read more »

What is the impact of COVID-19 treatments targeting intracellular Neu1?In a new study, researchers assessed the impact of targeting intracellular Neu1 on severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection.
Source: NewsMedical - 🏆 19. / 71 Read more »

Intranasal administration of liposomes displaying SARS-CoV-2 antigen induces mucosal immunityIntranasal administration of liposomes displaying SARS-CoV-2 antigen induces mucosal immunity MDPIOpenAccess UBuffalo SARSCoV2 COVID19 Coronavirus MucosalImmunity
Source: NewsMedical - 🏆 19. / 71 Read more »

Interactions between SIRT5 and SARS-CoV-2 Nsp14 proteinIn a new study, researchers investigated the interactions between sirtuin 5 (SIRT5) and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) nonstructural protein (Nsp14) protein.
Source: NewsMedical - 🏆 19. / 71 Read more »